Adler, V, Yin, Z, Tew, KD & Ronai, Z (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18, 6104–6111.
Akerlund, B, Jarstrand, C, Lindeke, B, Sönnerborg, A, Akerblad, A-Ac, & Rasool, O (1996) Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial. European Journal of Clinical Pharmacology 50, 457–461.
Allison, JB, Anderson, JA & Seeley, RD (1947) Some effects of methionine on the utilization of nitrogen in the adult dog. Journal of Nutrition 33, 361–370.
Beutler, E (1989) Nutritional and metabolic aspects of glutathione. Annual Review of Nutrition 9, 287–302.
Breithaupt, T, Eylar, EH, Baez, I, Vasquez, A, Colon-Martinez, S, Rodriquez, J & Kesseler, M (1996) N-acetylcysteine (NAC) reverses the supposed mitogenic responses of CD4+ and CD8+ T cells from aged rhesus monkeys. FASEB Journal 10, 1849 Abstr.
Breitkreutz, R, Holm, S, Pittack, N, Beichert, M, Babylon, A, Yodoi, J & Dröge, W (2000 a) Massive loss of sulphur in HIV infection. AIDS Research and Human Retroviruses 3, 203–209.
Breitkreutz, R, Pittak, N, Nebe, CT, Schuster, D, Brust, J, Beichert, M, Hack, V, Daniel, V, Edler, L & Dröge, W (2000 b) Improvement of immune functions in HIV infection by sulfur supplementation – two randomized trials. Journal of Molecular Medicine 78, 55–62.
Buhl, R, Holroyd, K, Mastrangeli, A, Cantin, AM, Jaffe, HA, Wells, FB, Saltini, C & Crystal, RG (1989) Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet ii, 1294–1298.
De Quay, B, Malinverni, R & Lauterburg, BH (1992) Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6, 815–819.
Dröge, W (1989) Metabolische Störungen bei HIV-Infektion (Metabolic disturbances with HIV infection). In Project News , no. 2, p. 4. Berlin, Germany: AIDS-Zentrum des Bundesgesundheitsamtes.
Dröge, W & Breitkreutz, R (1999) N-acetyl-cysteine in the therapy of HIV-positive patients. Current Opinion in Clinical Nutrition and Metabolic Care 2, 493–498.
Dröge, W, Eck, H-P, & Mihm, S (1992) HIV-induced cysteine deficiency and T cell dysfunctions – a rationale for treatment with N-acetyl-cysteine. Immunology Today 13, 211–214.
Dröge, W, Eck, H-P, Näher, H, Pekar, U & Daniel, V (1988) Abnormal amino acid concentrations in the blood of patients with acquired immune deficiency syndrome (AIDS) may contribute to the immunological defect. Biological Chemistry Hoppe-Seyler 369, 143–148.
Dröge, W & Holm, E (1997) Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB Journal 11, 1077–1089.
Dröge, W, Schulze-Osthoff, K, Mihm, S, Galter, D, Schenk, H, Eck, H-P, Roth, S & Gmünder, H (1994) Function of glutathione and glutathione disulfide in immunology and immunopathology. FASEB Journal 8, 1131–1138.
Eck, H-P, Gmünder, H, Hartmann, M, Petzoldt, D, Daniel, V & Dröge, W (1989) Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biological Chemistry Hoppe-Seyler 370, 101–108.
Eck, H-P, Stahl-Hennig, H, Hunsmann, G & Dröge, W (1991) Metabolic disorder as an early consequence of simian immunodeficiency virus infection in rhesus monkeys. Lancet 338, 346–347.
Fanger, MW, Hart, DA, Wells, JV & Nisonoff, A (1970) Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes. Journal of Immunology 105, 1043–1045.
Galter, D, Mihm, S & Droge, W (1994) Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. European Journal of Biochemistry 221, 639–648.
Gmünder, H & Dröge, W (1991) Differential effects of glutathione depletion on T cell subsets. Cellular Immunology 138, 229–237.
Gmünder, H, Eck, H-P, Benninghoff, B, Roth, S & Dröge, W (1990 a) Macrophages regulate intracellular glutathione levels of lymphocytes. Cellular Immunology 129, 32–46.
Gmünder, H, Roth, S, Eck, H-P, Gallas, H, Mihm, S & Dröge, W (1990 b) Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. Cellular Immunology 130, 520–528.
Gross, A, Hack, V, Stahl-Hennig, C & Dröge, W (1996) Elevated hepatic γ-glutamylcysteine synthetase activity and abnormal sulfate levels in liver and muscle tissue may explain abnormal cysteine and glutathione levels in SIV-infected rhesus macaques. AIDS Research and Human Retroviruses 12, 1639–1641.
Hack, V, Schmid, D, Breitkreutz, R, Stahl-Hennig, C, Drings, P, Kinscherf, R, Taut, F, Holm, E & Dröge, W (1997) Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence. FASEB Journal 11, 84–92.
Hamilos, DL & Wedner, HJ (1985) The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. Journal of Immunology 135, 2740–2747.
Herzenberg, LA, De Rosa, SC, Dubs, JG, Roederer, M, Anderson, MT, Ela, SW, Deresinski, SC & Herzenberg, LA (1997) Glutathione deficiency is associated with impaired survival in HIV disease. Proceedings of the National Academy of Sciences USA 94, 1967–1972.
Hortin, GL, Landt, M & Powderly, WG (1994) Changes in plasma amino acid concentrations in response to HIV-1 infection. Clinical Chemistry 40, 785–789.
Ishii, T, Sugita, Y & Bannai, S (1987) Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. Journal of Cellular Physiology 133, 330–336.
Jahoor, F, Jackson, A, Gazzard, B, Philips, G, Sharpstone, D, Frazer, ME & Heird, W (1999) Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. American Journal of Physiology 276, E205–E211.
Kinscherf, R, Fischbach, T, Mihm, S, Roth, S, Hohenhaus-Sievert, E, Weiss, C, Edler, L, Bärtsch, P & Dröge, W (1994) Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. FASEB Journal 8, 448–451.
Lim, J-S, Eck, H-P, Gmünder, H & Dröge, W (1992) Expression of increased immunogenicity by thiol releasing tumor variants. Cellular Immunology 140, 345–356.
Los, M, Schenk, H, Hexel, K, Baeuerle, PA, Dröge, W & Schulze-Osthoff, K (1995) IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO Journal 14, 3731–3740.
Lubaszewska, S, Pastuszewska, B & Kielanowski, J (1973) Effect of methionine supplementation of a protein-free diet on the nitrogen excretion in rats and pigs. Tierphysiologie, Tierernährung und Futtormittelkunde 31, 120–128.
Meister, A (1983) Selective modification of glutathione metabolism. Science 220, 471–477.
Meister, A & Anderson, ME (1983) Glutathione. Annual Review of Biochemistry 52, 711–760.
Meyer, M, Schreck, R & Baeuerle, PA (1993) H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO Journal 12, 2005–2015.
Mihm, S, Ennen, J, Pessara, U, Kurth, R & Dröge, W (1991) Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 5, 497–503.
Nakamura, H, Nakamura, K & Yodoi, J (1997) Redox regulation of cellular activation. Annual Review of Immunology 15, 351–369.
Okumura, J & Muramatsu, T (1978) Effect of dietary methionine and arginine on the excretion of nitrogen in cocks fed on a protein-free diet. Japanese Poultry Science 15, 69–73.
Pacht, ER, Diaz, P, Clanton, T, Hart, J & Gadek, JE (1997) Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time. Chest 112, 785–788.
Roederer, M, Staal, FJT, Osada, H & Herzenberg, LA (1991) CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as HIV infection progresses. International Immunology 3, 933–937.
Roth, S & Dröge, W (1987) Regulation of T cell activation and T cell growth factor (TCGF) production by hydrogen peroxide. Cellular Immunology 108, 417–424.
Roth, S & Dröge, W (1991) Regulation of interleukin-2 production, interleukin 2 mRNA expression and intracellular glutathione levels in ex vivo derived T lymphocytes by lactate. European Journal of Immunology 21, 1933–1937.
Roth, S & Dröge, W (1994) Glutathione reverses the inhibition of T cell responses by superoptimal numbers of 'non- professional' antigen presenting cells. Cellular Immunology 155, 183–194.
Schenk, H, Klein, M, Erdbrügger, W, Dröge, W & Schulze-Osthoff, K (1994) Distinct effects of thioredoxin and antioxidants on the activation of NFκB and AP-1. Proceedings of the National Academy of Sciences USA 91, 1672–1676.
Schreck, R, Rieber, P & Baeuerle, PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFκB transcription factor and HIV-1. EMBO Journal 10, 2247–2258.
Staal, FJ, Ela, SW, Roederer, M, Anderson, MT, Herzenberg, LA & Herzenberg, LA (1992) Glutathione deficiency and human immunodeficiency virus infection. Lancet 339, 909–912.
Walmsley, SL, Winn, LM, Harrosin, ML, Uetrecht, JP & Wells, PG (1997) Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications. AIDS 11, 1689–1697.
Webel, DM & Baker, DH (1999) Cystine is the first limiting amino acid for utilization of endogenous amino acids in chicks fed a protein-free diet. Nutrition Research 19, 569–577.
Yoshida, A & Moritoki, K (1974) Nitrogen sparing action of methionine and threonine in rats receiving a protein-free diet. Nutrition Reports International 9, 159–168.